Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R Matzke

Showing results (31-40 of 124) with videos related to

Pageof 13
Sort By:
Antimicrobial Agents and Chemotherapy|January 1, 1984
Hemodialysis elimination rates and clearance of gentamicin and tobramycinG R Matzke, C E Halstenson, W F Keane
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1991
Antimicrobial treatment of peritonitis associated with continuous ambulatory peritoneal dialysisS P Millikin, G R Matzke, W F Keane
Journal of Clinical Pharmacology|February 1, 1981
Acute phenytoin and primidone intoxication: a pharmacokinetic analysisG R Matzke, J C Cloyd, R J Sawchuk
Drug Intelligence & Clinical Pharmacy|June 1, 1983
Gentamicin and tobramycin dosing guidelines: an evaluationG R Matzke, W S Burkle, R L Lucarotti
Proceedings of the Clinical Dialysis and Transplant Forum|January 1, 1980
The effect of peritoneal dialysis of the pharmacokinetics of amikacinG R Matzke, N Salem, H Bockbrader, et al.
Clinical Pharmacokinetics|July 1, 1986
Clinical pharmacokinetics of vancomycinG R Matzke, G G Zhanel, D R Guay
Shock (Augusta, Ga.)|May 12, 2000
Unintended immunomodulation: part I. Effects of common clinical conditions on cytokine biosynthesisK M Alkharfy, J A Kellum, G R Matzke
Clinical Pharmacy|November 1, 1989
Variability in pharmacokinetic values for gentamicin, tobramycin, and netilmicin in patients with renal insufficiencyG R Matzke, S P Millikin, J M Kovarik
Journal of Clinical Pharmacology|March 1, 1987
Gentamicin disposition in young and elderly patients with various degrees of renal functionG R Matzke, J J Jameson, C E Halstenson
Clinical Pharmacy|January 1, 1983
Hemodialysis clearance of total and unbound lidocaineJ Jacobi, R W McGory, H McCoy, et al.
Pageof 13

Showing results (31-40 of 124) with videos related to

Sort By:
Pageof 13
Antimicrobial Agents and Chemotherapy|January 1, 1984
Hemodialysis elimination rates and clearance of gentamicin and tobramycinG R Matzke, C E Halstenson, W F Keane
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1991
Antimicrobial treatment of peritonitis associated with continuous ambulatory peritoneal dialysisS P Millikin, G R Matzke, W F Keane
Journal of Clinical Pharmacology|February 1, 1981
Acute phenytoin and primidone intoxication: a pharmacokinetic analysisG R Matzke, J C Cloyd, R J Sawchuk
Drug Intelligence & Clinical Pharmacy|June 1, 1983
Gentamicin and tobramycin dosing guidelines: an evaluationG R Matzke, W S Burkle, R L Lucarotti
Proceedings of the Clinical Dialysis and Transplant Forum|January 1, 1980
The effect of peritoneal dialysis of the pharmacokinetics of amikacinG R Matzke, N Salem, H Bockbrader, et al.
Clinical Pharmacokinetics|July 1, 1986
Clinical pharmacokinetics of vancomycinG R Matzke, G G Zhanel, D R Guay
Shock (Augusta, Ga.)|May 12, 2000
Unintended immunomodulation: part I. Effects of common clinical conditions on cytokine biosynthesisK M Alkharfy, J A Kellum, G R Matzke
Clinical Pharmacy|November 1, 1989
Variability in pharmacokinetic values for gentamicin, tobramycin, and netilmicin in patients with renal insufficiencyG R Matzke, S P Millikin, J M Kovarik
Journal of Clinical Pharmacology|March 1, 1987
Gentamicin disposition in young and elderly patients with various degrees of renal functionG R Matzke, J J Jameson, C E Halstenson
Clinical Pharmacy|January 1, 1983
Hemodialysis clearance of total and unbound lidocaineJ Jacobi, R W McGory, H McCoy, et al.
Pageof 13